A first-of-its-kind clinical trial has launched at paediatric centres nationwide to more quickly and precisely treat babies and young children with rare, embryonal brain tumours: aggressive cancers with low survival rates and poor outcomes after treatment.
DECRYPT-BABYBRAIN uses a novel standard of care approach developed at SickKids hospital to deliver chemotherapy directly to the brain and spinal fluid and side-step the potentially damaging effects of radiation on the developing brain.
Childhood Cancer Canada is honoured and proud to be a part of the unique coalition of Canadian charities and funders, who partnered to create the DECRYPT Research Grant, designed to drive transformative research in childhood embryonal brain tumours.
Coalition members include Kindred Foundation, Cancer Research Society, Phoebe Rose Rocks Foundation, Brain Tumour Foundation of Canada, The Miracle Marnie Foundation, Childhood Cancer Canada and Tali’s Fund. Additional support from the ACCESS network is helping to support the trial’s pan-Canadian reach.
To read the full release from SickKids and learn all about the DECRYPT-BABYBRAIN clinical trial, please visit – https://bit.ly/3LMY3YV
